Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart.

Edin ML, Wang Z, Bradbury JA, Graves JP, Lih FB, DeGraff LM, Foley JF, Torphy R, Ronnekleiv OK, Tomer KB, Lee CR, Zeldin DC.

FASEB J. 2011 Oct;25(10):3436-47. doi: 10.1096/fj.11-188300. Epub 2011 Jun 22.

PMID:
21697548
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.

Xu X, Zhang XA, Wang DW.

Adv Drug Deliv Rev. 2011 Jul 18;63(8):597-609. doi: 10.1016/j.addr.2011.03.006. Epub 2011 Apr 6. Review.

PMID:
21477627
[PubMed - indexed for MEDLINE]
3.

Epoxyeicosatrienoic acid pathway in human health and diseases.

Bellien J, Joannides R.

J Cardiovasc Pharmacol. 2013 Mar;61(3):188-96. doi: 10.1097/FJC.0b013e318273b007. Review.

PMID:
23011468
[PubMed - indexed for MEDLINE]
4.

Arachidonic acid cytochrome P450 epoxygenase pathway.

Spector AA.

J Lipid Res. 2009 Apr;50 Suppl:S52-6. doi: 10.1194/jlr.R800038-JLR200. Epub 2008 Oct 23. Review.

PMID:
18952572
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation.

Deng Y, Theken KN, Lee CR.

J Mol Cell Cardiol. 2010 Feb;48(2):331-41. doi: 10.1016/j.yjmcc.2009.10.022. Epub 2009 Nov 3. Review.

PMID:
19891972
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Cytochrome p450 2C (CYP2C) in ischemic heart injury and vascular dysfunction.

Chehal MK, Granville DJ.

Can J Physiol Pharmacol. 2006 Jan;84(1):15-20. Review.

PMID:
16845886
[PubMed - indexed for MEDLINE]
7.

Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids.

Spiecker M, Liao JK.

Arch Biochem Biophys. 2005 Jan 15;433(2):413-20. Review.

PMID:
15581597
[PubMed - indexed for MEDLINE]
8.

The roles of cytochrome p450 in ischemic heart disease.

Sato M, Yokoyama U, Fujita T, Okumura S, Ishikawa Y.

Curr Drug Metab. 2011 Jul;12(6):526-32. Review.

PMID:
21476972
[PubMed - indexed for MEDLINE]
9.

Cytochrome P450 epoxygenase CYP2J2 and the risk of coronary artery disease.

Spiecker M, Liao J.

Trends Cardiovasc Med. 2006 Aug;16(6):204-8. Review.

PMID:
16839864
[PubMed - indexed for MEDLINE]
10.

Soluble epoxide hydrolase: a new target for cardioprotection.

Gross GJ, Nithipatikom K.

Curr Opin Investig Drugs. 2009 Mar;10(3):253-8. Review.

PMID:
19333883
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Genetic variation in the cytochrome P450 epoxygenase pathway and cardiovascular disease risk.

Theken KN, Lee CR.

Pharmacogenomics. 2007 Oct;8(10):1369-83. Review.

PMID:
17979511
[PubMed - indexed for MEDLINE]
12.

Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases.

Zordoky BN, El-Kadi AO.

Pharmacol Ther. 2010 Mar;125(3):446-63. doi: 10.1016/j.pharmthera.2009.12.002. Epub 2010 Jan 20. Review.

PMID:
20093140
[PubMed - indexed for MEDLINE]
13.

Cyclic AMP-dependent modulation of cardiac L-type Ca2+ and transient outward K+ channel activities by epoxyeicosatrienoic acids.

Xiao YF.

Prostaglandins Other Lipid Mediat. 2007 Jan;82(1-4):11-8. Epub 2006 Jul 7. Review.

PMID:
17164128
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk